MARKET

ARMP

ARMP

Armata Pharmctcl
AMEX
8.59
+0.22
+2.63%
Closed 18:07 03/30 EDT
OPEN
8.37
PREV CLOSE
8.37
HIGH
9.12
LOW
8.37
VOLUME
29.20K
TURNOVER
6.51K
52 WEEK HIGH
16.34
52 WEEK LOW
0.8981
MARKET CAP
314.68M
P/E (TTM)
-1.7911
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ARMP last week (0323-0327)?
Weekly Report · 1d ago
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Benzinga · 3d ago
Armata Pharmaceuticals GAAP EPS of -$3.42, revenue of $1.1M
Seeking Alpha · 5d ago
Armata Pharmaceuticals Q4 EPS $(3.43) Misses $(0.28) Estimate, Sales $1.085M Beat $750.000K Estimate
Benzinga · 5d ago
Armata Pharmaceuticals reports Q4 EPS ($3.42) vs. (23c) last year
TipRanks · 5d ago
*Armata Pharmaceuticals 4Q Loss/Shr $4.80 >ARMP
Dow Jones · 5d ago
Press Release: Armata Pharmaceuticals Announces -2-
Dow Jones · 5d ago
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results
PR Newswire · 5d ago
More
About ARMP
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its bacteriophage-based technology. The Company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. It is advancing two lead candidates, such as AP-PA02 and AP-SA02, to address both chronic and acute bacterial infections. Its lead phage candidate, inhaled AP-PA02, is focused primarily on the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa. In parallel, it has an acute bacterial infection clinical development plan focused on Staphylococcus aureus bacteremia, a difficult-to-treat and often life-threatening infection.

Webull offers Armata Pharmaceuticals Inc stock information, including AMEX: ARMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARMP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARMP stock methods without spending real money on the virtual paper trading platform.